Shares in Alcon Inc. have recently benefitted from a regain of interest by market participants. The technical chart pattern suggests a continuation of the upward movement. Investors have an opportunity to buy the stock and target the CHF 60.4.
The company usually posts poor financials for mid or long term investments.
For a short-term investment strategy, the company has poor fundamentals.
Stock prices approach a strong long-term resistance in weekly data at CHF 62.01.
The stock is close to a major daily resistance at CHF 62.38, which should be gotten rid of so as to gain new appreciation potential.
The company has insufficient levels of profitability.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The company's enterprise value to sales, at 4.59 times its current sales, is high.
The company is not the most generous with respect to shareholders' compensation.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the past year, analysts have significantly revised downwards their profit estimates.
ę MarketScreener.com 2020
Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.